Rowena Kemp
Impact in
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
-
- Hormonal Regulation and Hypertension
Papers in
- Biochemistry 11
- Eicosanoids and Hypertension Pharmacology 11
-
- Heme Oxygenase-1 and Carbon Monoxide 5
- Co-authors
- Alberto Nasjletti (10 shared papers)Michal L. Schwartzman (5 shared papers)John R. Falck (4 shared papers)Harpreet Singh (2 shared papers)Dao‐Hong Lin (3 shared papers)Wen‐Hui Wang (3 shared papers)Huan Deng (2 shared papers)Francisca Rodríguez (2 shared papers)
- Journals
- Hypertension (6 papers)Prostaglandins & Other Lipid Mediators (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of the American Society of Nephrology (1 paper)PROTEOMICS - CLINICAL APPLICATIONS (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Rowena Kemp
15 papers receiving 593 citations
Peers
Comparison fields: 5 of 69
- Biochemistry 308
- Endocrinology, Diabetes and Metabolism 199
- Transplantation 22
- Pharmacology 70
- Pathology and Forensic Medicine 94
Countries citing papers authored by Rowena Kemp
This map shows the geographic impact of Rowena Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowena Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowena Kemp more than expected).
Fields of papers citing papers by Rowena Kemp
This network shows the impact of papers produced by Rowena Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowena Kemp. The network helps show where Rowena Kemp may publish in the future.
Co-authors
The 25 scholars most cited alongside Rowena Kemp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 121 | |
| 2 | 2004 | 85 | |
| 3 | 2003 | 50 | |
| 4 | 2003 | 48 | |
| 5 | 2008 | 46 | |
| 6 | 2003 | 40 | |
| 7 | 2008 | 38 | |
| 8 | 2007 | 37 | |
| 9 | 2006 | 33 | |
| 10 | 2004 | 33 | |
| 11 | 2004 | 32 | |
| 12 | 2005 | 25 | |
| 13 | 2011 | 7 | |
| 14 | 2000 | 2 | |
| 15 | 2000 | 2 |
About Rowena Kemp
Rowena Kemp is a scholar working on Biochemistry, Molecular Biology, Endocrinology, Diabetes and Metabolism, Physiology and Pharmacology, having authored 15 papers that have together received 599 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (11 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers), Hormonal Regulation and Hypertension (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Neuroscience of respiration and sleep (2 papers), Alcohol Consumption and Health Effects (2 papers), Glaucoma and retinal disorders (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Biochemistry (308 citations), Endocrinology, Diabetes and Metabolism (199 citations), Transplantation (22 citations), Pharmacology (70 citations) and Pathology and Forensic Medicine (94 citations). Rowena Kemp has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Alberto Nasjletti, Michal L. Schwartzman, John R. Falck, Harpreet Singh, Dao‐Hong Lin, Wen‐Hui Wang, Huan Deng, Francisca Rodríguez, Jennifer Cheng and Tsuneo Ishizuka. Their work appears in journals such as Hypertension, Prostaglandins & Other Lipid Mediators, Journal of Pharmacology and Experimental Therapeutics, Journal of the American Society of Nephrology and PROTEOMICS - CLINICAL APPLICATIONS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.